Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debayan Sil

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|November 8, 2025
Innovative approaches in HELICOBACTER pylori therapy: Clinical trials and advancements in Gastro-Retentive drug delivery systemsPrachi Pandey, Debayan Sil, K M Komal, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|July 31, 2025
Apremilast in Psoriasis: Current Landscape and PerspectivesDinesh Kumar, Debayan Sil, Balak Das Kurmi, et al.
Assay and Drug Development Technologies|January 8, 2025
Future Prospects and Regulatory Pathways for Invasome Technologies in Transdermal Drug DeliveryDinesh Kumar, Debayan Sil, Balak Das Kurmi, et al.
Experimental Eye Research|March 19, 2026
Optimized polymeric micellar In situ gel formulation incorporating luliconazole for targeted management of fungal endophthalmitis: In vitro characterization, ex vivo ocular permeation, and in vivo ocular irritation evaluationDebayan Sil, Manish Kumar, Rashmi Ghosh, et al.
Inflammopharmacology|January 8, 2025
Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insightsKumari Komal, Rashmi Ghosh, Debayan Sil, et al.
RSC Advances|October 13, 2025
Comprehensive insights into the role of nanocarriers in advancing azole-based ocular therapeuticsDebayan Sil, Rashmi Ghosh, Dinesh Kumar, et al.
Molecular Biology Reports|June 4, 2025
Investigating postbiotics as innovative adjuvants: deciphering the gut-breast connection in breast Cancer therapy, from gut microbiome to personalized medicineRashmi Ghosh, Debayan Sil, Rohit Sharma, et al.
Current Drug Targets|May 10, 2024
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global ImpactDebayan Sil, Shreastha Gautam, Shubhi Saxena, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|November 8, 2025
Innovative approaches in HELICOBACTER pylori therapy: Clinical trials and advancements in Gastro-Retentive drug delivery systemsPrachi Pandey, Debayan Sil, K M Komal, et al.
Recent Advances in Inflammation & Allergy Drug Discovery|July 31, 2025
Apremilast in Psoriasis: Current Landscape and PerspectivesDinesh Kumar, Debayan Sil, Balak Das Kurmi, et al.
Assay and Drug Development Technologies|January 8, 2025
Future Prospects and Regulatory Pathways for Invasome Technologies in Transdermal Drug DeliveryDinesh Kumar, Debayan Sil, Balak Das Kurmi, et al.
Experimental Eye Research|March 19, 2026
Optimized polymeric micellar In situ gel formulation incorporating luliconazole for targeted management of fungal endophthalmitis: In vitro characterization, ex vivo ocular permeation, and in vivo ocular irritation evaluationDebayan Sil, Manish Kumar, Rashmi Ghosh, et al.
Inflammopharmacology|January 8, 2025
Advancements in nose-to-brain drug targeting for Alzheimer's disease: a review of nanocarriers and clinical insightsKumari Komal, Rashmi Ghosh, Debayan Sil, et al.
RSC Advances|October 13, 2025
Comprehensive insights into the role of nanocarriers in advancing azole-based ocular therapeuticsDebayan Sil, Rashmi Ghosh, Dinesh Kumar, et al.
Molecular Biology Reports|June 4, 2025
Investigating postbiotics as innovative adjuvants: deciphering the gut-breast connection in breast Cancer therapy, from gut microbiome to personalized medicineRashmi Ghosh, Debayan Sil, Rohit Sharma, et al.
Current Drug Targets|May 10, 2024
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global ImpactDebayan Sil, Shreastha Gautam, Shubhi Saxena, et al.
Pageof 1